Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.110
-0.020 (-0.48%)
At close: Dec 30, 2025, 4:00 PM EST
4.120
+0.010 (0.23%)
After-hours: Dec 30, 2025, 7:59 PM EST
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.14 billion as of December 30, 2025. Its market cap has increased by 6.84% in one year.
Market Cap
2.14B
Enterprise Value
1.56B
1-Year Change
6.84%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.14B, a decrease of -57.85%. That is a compound annual growth rate of -16.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.14B | -19.77% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |